1-8 of 8
Mauricette Michalet
Close
Sort by
Journal Articles

The Hierarchy of Alternative Donors for Allogeneic Hematopoietic Stem Cell Transplantation in Poor Risk AML in CR1: 10/10 Matched Unrelated Donors Still to be Preferred over Haplo-Identical Donors or Umbilical Cord Blood

Jurjen Versluis, MD, Myriam Labopin, MD, Gerard Socie, MD PhD, Wu Depei, MD, Liisa Volin, MD, Didier Blaise, MD PhD, Noel Milpied, MD PhD, Charles Craddock, MDPhD, Ibrahim Yakoub-Agha, MDPhD, Johan Maertens, MD PhD, Per T. Ljungman, MD PhD, Anne Huynh, MD, Mauricette Michalet, MD, Eric Deconinck, MD PhD, Patrice Chevallier, MD PhD, Nigel Russell, Jakob R Passweg, MD, Gert J Ossenkoppele, MD PhD, Bob Lowenberg, MDPhD, Mohamad Mohty, MD PhD, Jan J Cornelissen, MD PhD, Arnon Nagler, MD
Journal: Blood
Blood (2014) 124 (21): 681.
https://doi.org/10.1182/blood.V124.21.681.681
Published: 2014
Journal Articles

Prolonged Overall Survival with Pomalidomide and Dexamethasone in Myeloma Characterized with End Stage Disease.

Xavier Leleu, MD, PhD, Murielle Roussel, Bertrand Arnulf, MD, PhD, Philippe Moreau, MD, Catherine Traulle, MD, Mauricette Michalet, MD, Claire Mathiot, MD, Marie Odile Petillon, MD, Gerald Marit, MD, Margaret Macro, MD, Brigitte Pegourie, MD, Brigitte Kolb, MD, Anne Marie Stoppa, Sabine Brechiniac, MD, Laurent Garderet, MD, Bruno Royer, MD, Cyrille Hulin, MD, Lotfi Benbouker, Olivier Decaux, Denis Caillot, M.D., Martine Escoffre-Barbe, Jean Paul Fermand, MD, Herve AvetLoiseau, Michel Attal, MD, Thierry Facon, MD
Journal: Blood
Blood (2012) 120 (21): 2961.
https://doi.org/10.1182/blood.V120.21.2961.2961
Published: 2012
Journal Articles

High Response Rates to Pomalidomide and Dexamethasone in Patients with Refractory Myeloma, Final Analysis of IFM 2009-02

Xavier Leleu, MD, PhD, Michel Attal, MD, Bertrand Arnulf, MD, PhD, Philippe Moreau, MD, Catherine Traulle, MD, Mauricette Michalet, MD, Gerald Marit, MD, PhD, Claire Mathiot, MD, Marie Odile Petillon, MD, Margaret Macro, MD, Murielle Roussel, Brigitte Pegourie, MD, Brigitte Kolb, MD, Anne-Marie Stoppa, MD, Sabine Brechiniac, MD, Laurent Garderet, MD, Bruno Royer, MD, Cyrille Hulin, MD, Lotfi Benboubker, MD, PhD, Olivier Decaux, MD, PhD, Denis Caillot, MD, Martine Escoffre-Barbe, MD, Jean Paul Fermand, MD, Hervé Avet-Loiseau, MD, PhD, Thierry Facon, MD
Journal: Blood
Blood (2011) 118 (21): 812.
https://doi.org/10.1182/blood.V118.21.812.812
Published: 2011
Journal Articles

Phase 2 Study of 2 Modalities of Pomalidomide (CC4047) Plus Low-Dose Dexamethasone as Therapy for Relapsed Multiple Myeloma. IFM 2009-02

Xavier Leleu, MD, PhD, Michel Attal, Philippe Moreau, MD, Alain Duhamel, Jean Paul Fermand, Mauricette Michalet, Catherine Traulle, Gerald Marit, Murielle Roussel, Brigitte Kolb, Bertrand Arnulf, Laurent Garderet, Claire Mathiot, Margaret Macro, Marie Odile Petillon, Brigitte Pegourie, Anne Marie Stoppa, Sabine Brechiniac, Bruno Royer, Lotfi Benboubker, Denis Caillot, Martine Escoffre-Barbe, Cyrille Hulin, Jean-Luc Harousseau, MD, Hervé Avet-Loiseau, Thierry Facon
Journal: Blood
Blood (2010) 116 (21): 859.
https://doi.org/10.1182/blood.V116.21.859.859
Published: 2010
Journal Articles

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Ambroise Marcais, Karin Bilger, MD, Raphael Porcher, Marie Robin, Mohamad Mohty, Mauricette Michalet, Didier Blaise, MD, Stephane Vigouroux, Pierre Bordigoni, Patrice Ceballos, Eric Deconinck, Nathalie Dehdin, Bernard Rio, MD, Jacques-Olivier Bay, MD, PhD, Cécile Pautas, Frederic Garban, Norbert Ifrah, Felipe Suarez, Gaelle Guillerm, MD, Nathalie Contentin, MD, Jean-Henri Bourhis, Marc Bernard, Jérôme Cornillon, Anne Huynh, MD, Ibrahim yakoub Agha, Anne Sirvent, Loic Fouillard, Agnes Buzyn, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2359.
https://doi.org/10.1182/blood.V116.21.2359.2359
Published: 2010
Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Louis Terriou, Zina Chir, Helene Esperou, Jean-Michel Boiron, Jean-Paul Vernant, Nicole Gratecos, Mauricette Michalet, Noel Milpied, Jean-Pierre Jouet, Ibrahim Yakoub-Agha, Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire
Journal: Blood
Blood (2007) 110 (11): 4924.
https://doi.org/10.1182/blood.V110.11.4924.4924
Published: 2007
Journal Articles

Mutation Status of Imatinib Mesylate-Resistants CML Patients and Clinical Outcomes: A French Multicenter Retrospective Study for the fiLMC Group.

Selim Corm, MD, Franck Nicollini, MD, Dominique Borie, MD, Nathalie Sorel, MD, Thibault Leguay, MD, Sandrine Hayette, PhD, Thierry Facon, MD, PhD, Laurence Roy, MD, Stephane Giraudier, MD, PhD, Gerald Marit, MD, Claude Preudhomme, MD, PhD, Mauricette Michalet, MD, PhD, Francois-Xavier Mahon, MD, PhD, Michel Thuilliez, MD, PhD, Francois Guilhot, MD, PhD, Catherine Roche-Lestienne, PhD
Journal: Blood
Blood (2004) 104 (11): 275.
https://doi.org/10.1182/blood.V104.11.275.275
Published: 2004
Journal Articles

Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor–mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation

Clinical Trials & Observations
Valérie Lapierre, Anne Aupérin, Hakim Tayebi, Jacqueline Chabod, Philippe Saas, Mauricette Michalet, Sylvie François, Frédéric Garban, Christine Giraud, Dominique Tramalloni, Nadia Oubouzar, Didier Blaise, Matthieu Kuentz, Eric Robinet, Pierre Tiberghien
Journal: Blood
Blood (2002) 100 (4): 1484–1489.
https://doi.org/10.1182/blood-2001-11-0039
Published: 2002